Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity

    Alemtuzumab is used with reduced-toxicity conditioning (RTC) in allogeneic hematopoietic cell transplantation (HCT), demonstrating efficacy and feasibility for patients with inborn errors of immunity (IEI) in ...

    Satoshi Miyamoto, Daiki Niizato, Dan Tomomasa in Journal of Clinical Immunology (2024)

  2. No Access

    Article

    Graft-versus-host disease-free, relapse-free, second transplant-free survival in allogeneic hematopoietic cell transplantation for genetic disorders

    Koji Kawaguchi, Katsutsugu Umeda, Satoshi Miyamoto in Bone Marrow Transplantation (2023)

  3. No Access

    Article

    Clinical and Genetic Characterization of Patients with Artemis Deficiency in Japan

    Artemis is an exonuclease essential for V(D)J recombination and repair of DNA double-stranded breaks. Pathogenic variants in DCLRE1C encoding Artemis cause TBNK+ severe combined immunodeficiency (SCID), and pat...

    Kento Inoue, Satoshi Miyamoto, Dan Tomomasa, Eriko Adachi in Journal of Clinical Immunology (2023)

  4. Article

    Open Access

    Clinical utility of markerless motion capture for kinematic evaluation of sit-to-stand during 30 s-CST at one year post total knee arthroplasty: a retrospective study

    Although the importance of kinematic evaluation of the sit-to-stand (STS) test of total knee arthroplasty (TKA) patients is clear, there have been no reports analyzing STS during the 30-s chair sit-up test (30...

    Katsuya Onitsuka, Keisuke Kubota, Moeka Yokoyama in BMC Musculoskeletal Disorders (2023)

  5. No Access

    Article

    B-Cell Immune Reconstitution with Mixed Chimerism After Hematopoietic Cell Transplantation in a Patient with Severe Combined Immunodeficiency

    Satoshi Miyamoto, Takasuke Ebato, Eri Watanabe in Journal of Clinical Immunology (2022)

  6. No Access

    Article

    Clinical and immunophenotypic characteristics of familial leukemia predisposition caused by PAX5 germline variants

    Adela Escudero, Masatoshi Takagi, Franziska Auer, Ulrike Anne Friedrich in Leukemia (2022)

  7. No Access

    Article

    Conditioning regimens for inborn errors of immunity: current perspectives and future strategies

    Inborn errors of immunity (IEI) are caused by germline genetic mutations, resulting in defects of innate or acquired immunity. Hematopoietic cell transplantation (HCT) is indicated for curative therapy especia...

    Akira Nishimura, Satoshi Miyamoto, Kohsuke Imai in International Journal of Hematology (2022)

  8. No Access

    Article

    Hematopoietic Cell Transplantation for Inborn Errors of Immunity Other than Severe Combined Immunodeficiency in Japan: Retrospective Analysis for 1985–2016

    Hematopoietic cell transplantation (HCT) is a curative therapy for most patients with inborn errors of immunity (IEI). We conducted a nationwide study on HCT for patients with IEI other than severe combined im...

    Satoshi Miyamoto, Katsutsugu Umeda, Mio Kurata in Journal of Clinical Immunology (2022)

  9. Article

    Hematopoietic Cell Transplantation for Severe Combined Immunodeficiency Patients: a Japanese Retrospective Study

    Hematopoietic cell transplantation (HCT) is a curative therapy for patients with severe combined immunodeficiency (SCID). Here, we conducted a nationwide study to assess the outcome of SCID patients after HCT ...

    Satoshi Miyamoto, Katsutsugu Umeda, Mio Kurata in Journal of Clinical Immunology (2021)

  10. No Access

    Article

    Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases

    The purpose of our study was to compare the safety and efficacy of hematopoietic cell transplantation (HCT) using fludarabine (Flu)-based reduced intensity conditioning (RIC) with busulfan (BU) or melphalan (M...

    Akira Nishimura, Yuki Aoki, Yasuyoshi Ishiwata in Journal of Clinical Immunology (2021)

  11. Article

    Open Access

    Neural network-based modeling of the number of microbubbles generated with four circulation factors in cardiopulmonary bypass

    The need for the estimation of the number of microbubbles (MBs) in cardiopulmonary bypass surgery has been recognized among surgeons to avoid postoperative neurological complications. MBs that exceed the diame...

    Satoshi Miyamoto, Zu Soh, Shigeyuki Okahara, Akira Furui in Scientific Reports (2021)

  12. No Access

    Chapter

    Glycemic Control and Future Perspectives for Treatment

    Studies have demonstrated that strict glycemic control can prevent the progression of diabetic kidney disease (DKD) in patients with microalbuminuria. Glycemic control targeting an HbA1c level of <7% is recomm...

    Satoshi Miyamoto, Kenichi Shikata in Diabetic Kidney Disease (2021)

  13. Article

    Open Access

    Dysfunction of CD8 + PD-1 + T cells in type 2 diabetes caused by the impairment of metabolism-immune axis

    The metabolic changes and dysfunction in CD8 + T cells may be involved in tumor progression and susceptibility to virus infection in type 2 diabetes (T2D). In C57BL/6JJcl mice fed with high fat-high sucrose ch...

    Ichiro Nojima, Shingo Eikawa, Nahoko Tomonobu, Yoshiko Hada in Scientific Reports (2020)

  14. No Access

    Article

    The hypoglycemia-prevention effect of sensor-augmented pump therapy with predictive low glucose management in Japanese patients with type 1 diabetes mellitus: a short-term study

    The predictive low glucose management (PLGM) system was introduced in March 2018 in Japan. Although there are some reports demonstrating the benefit of PLGM in preventing hypoglycemia, no data are currently av...

    Akihiro Katayama, Atsuhito Tone, Mayu Watanabe in Diabetology International (2020)

  15. Article

    Open Access

    Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports

    Acquired partial lipoatrophy has been reported after bone marrow transplantation during childhood; however, no adult cases have previously been reported. We herein report two adult cases of acquired partial li...

    Yusuke Shibata, Atsuko Nakatsuka, Jun Eguchi in Journal of Medical Case Reports (2018)

  16. No Access

    Article

    Hematopoietic stem cell transplantation for pulmonary alveolar proteinosis associated with primary immunodeficiency disease

    Pulmonary alveolar proteinosis (PAP) is a rare disorder that is characterized by the excessive accumulation of surfactant-like materials in the alveoli, leading to hypoxemic respiratory failure. We describe tw...

    Mari Tanaka-Kubota, Koji Shinozaki, Satoshi Miyamoto in International Journal of Hematology (2018)

  17. No Access

    Article

    Droplet Digital PCR-Based Chimerism Analysis for Primary Immunodeficiency Diseases

    In the current study, we aimed to accurately evaluate donor/recipient or male/female chimerism in samples from patients who underwent hematopoietic stem cell transplantation (HSCT).

    Tsubasa Okano, Yuki Tsujita, Hirokazu Kanegane in Journal of Clinical Immunology (2018)

  18. No Access

    Article

    HLA haploidentical hematopoietic cell transplantation using clofarabine and busulfan for refractory pediatric hematological malignancy

    Haploidentical hematopoietic cell transplantation (HCT) conditioning with clofarabine and target area under the blood concentration–time curve (AUC)-based busulfan adjustment was performed in three patients wi...

    Masatoshi Takagi, Yasuyoshi Ishiwata, Yuki Aoki in International Journal of Hematology (2017)

  19. No Access

    Article

    Bone substitutes and implantation depths for subchondral bone repair in osteochondral defects of porcine knee joints

    The purpose of this study was to identify the optimal material and implantation method for subchondral bone repair.

    Tomohiko Matsuo, Keisuke Kita, Tatsuo Mae in Knee Surgery, Sports Traumatology, Arthros… (2015)

  20. Article

    Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis

    Prostaglandin E synthase (PGES) including isoenzymes of membrane-associated PGES (mPGES)-1, mPGES-2, and cytosolic PGES (cPGES) is the recently identified terminal enzyme of the arachidonic acid cascade. PGES ...

    Fumiaki Kojima, Hiroaki Naraba, Satoshi Miyamoto, Moroe Beppu in Arthritis Res Ther (2004)

previous disabled Page of 2